Literature DB >> 10933724

Reovirus-induced apoptosis is mediated by TRAIL.

P Clarke1, S M Meintzer, S Gibson, C Widmann, T P Garrington, G L Johnson, K L Tyler.   

Abstract

Members of the tumor necrosis factor (TNF) receptor superfamily and their activating ligands transmit apoptotic signals in a variety of systems. We now show that the binding of TNF-related, apoptosis-inducing ligand (TRAIL) to its cellular receptors DR5 (TRAILR2) and DR4 (TRAILR1) mediates reovirus-induced apoptosis. Anti-TRAIL antibody and soluble TRAIL receptors block reovirus-induced apoptosis by preventing TRAIL-receptor binding. In addition, reovirus induces both TRAIL release and an increase in the expression of DR5 and DR4 in infected cells. Reovirus-induced apoptosis is also blocked following inhibition of the death receptor-associated, apoptosis-inducing molecules FADD (for FAS-associated death domain) and caspase 8. We propose that reovirus infection promotes apoptosis via the expression of DR5 and the release of TRAIL from infected cells. Virus-induced regulation of the TRAIL apoptotic pathway defines a novel mechanism for virus-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933724      PMCID: PMC112347          DOI: 10.1128/jvi.74.17.8135-8139.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Bovine herpesvirus 4 BORFE2 protein inhibits Fas- and tumor necrosis factor receptor 1-induced apoptosis and contains death effector domains shared with other gamma-2 herpesviruses.

Authors:  G H Wang; J Bertin; Y Wang; D A Martin; J Wang; K J Tomaselli; R C Armstrong; J I Cohen
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

Authors:  H Walczak; M A Degli-Esposti; R S Johnson; P J Smolak; J Y Waugh; N Boiani; M S Timour; M J Gerhart; K A Schooley; C A Smith; R G Goodwin; C T Rauch
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

3.  Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2.

Authors:  S E Rodgers; E S Barton; S M Oberhaus; B Pike; C A Gibson; K L Tyler; T S Dermody
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis.

Authors:  S M Oberhaus; R L Smith; G H Clayton; T S Dermody; K L Tyler
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 5.  Caspases: intracellular signaling by proteolysis.

Authors:  G S Salvesen; V M Dixit
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

6.  TRAIL/Apo-2-ligand-induced apoptosis in human T cells.

Authors:  I Jeremias; I Herr; T Boehler; K M Debatin
Journal:  Eur J Immunol       Date:  1998-01       Impact factor: 5.532

7.  Characterization of two receptors for TRAIL.

Authors:  P Schneider; J L Bodmer; M Thome; K Hofmann; N Holler; J Tschopp
Journal:  FEBS Lett       Date:  1997-10-27       Impact factor: 4.124

8.  Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha.

Authors:  F Su; R J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

9.  Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction.

Authors:  H Wajant; F J Johannes; E Haas; K Siemienski; R Schwenzer; G Schubert; T Weiss; M Grell; P Scheurich
Journal:  Curr Biol       Date:  1998-01-15       Impact factor: 10.834

10.  Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.

Authors:  J Zhang; D Cado; A Chen; N H Kabra; A Winoto
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

View more
  83 in total

1.  Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand.

Authors:  Alexander Kotelkin; Elena A Prikhod'ko; Jeffrey I Cohen; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 2.  Reovirus receptors and pathogenesis.

Authors:  J Craig Forrest; Terence S Dermody
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

3.  The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.

Authors:  Erik L Brincks; Prajwal Gurung; Ryan A Langlois; Emily A Hemann; Kevin L Legge; Thomas S Griffith
Journal:  J Immunol       Date:  2011-09-21       Impact factor: 5.422

Review 4.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

5.  Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblasts.

Authors:  Tao Peng; Jia Zhu; Yon Hwangbo; Lawrence Corey; Roger E Bumgarner
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

Review 6.  Reovirus: a targeted therapeutic--progress and potential.

Authors:  Radhashree Maitra; Mohammad H Ghalib; Sanjay Goel
Journal:  Mol Cancer Res       Date:  2012-10-04       Impact factor: 5.852

Review 7.  The TRAIL to viral pathogenesis: the good, the bad and the ugly.

Authors:  Nathan Cummins; Andrew Badley
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

Review 8.  Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation.

Authors:  Olaf Hoffmann; Frauke Zipp; Joerg R Weber
Journal:  J Mol Med (Berl)       Date:  2009-05-17       Impact factor: 4.599

9.  Bid regulates the pathogenesis of neurotropic reovirus.

Authors:  Pranav Danthi; Andrea J Pruijssers; Angela K Berger; Geoffrey H Holm; Sandra S Zinkel; Terence S Dermody
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

10.  Soluble TRAIL in normal pregnancy and acute pyelonephritis: a potential explanation for the susceptibility of pregnant women to microbial products and infection.

Authors:  Piya Chaemsaithong; Roberto Romero; Steven J Korzeniewski; Alyse G Schwartz; Tamara Stampalija; Zhong Dong; Lami Yeo; Edgar Hernandez-Andrade; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.